Logo image of EAST

EASTSIDE DISTILLING INC (EAST) Stock Fundamental Analysis

NASDAQ:EAST - Nasdaq - US2778024016 - Common Stock - Currency: USD

0.8867  +0.01 (+0.88%)

After market: 0.8503 -0.04 (-4.11%)

Fundamental Rating

1

Overall EAST gets a fundamental rating of 1 out of 10. We evaluated EAST against 32 industry peers in the Beverages industry. Both the profitability and financial health of EAST have multiple concerns. EAST is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

EAST had negative earnings in the past year.
EAST had a negative operating cash flow in the past year.
In the past 5 years EAST always reported negative net income.
EAST had a negative operating cash flow in each of the past 5 years.
EAST Yearly Net Income VS EBIT VS OCF VS FCFEAST Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -5M -10M -15M

1.2 Ratios

EAST's Return On Assets of -47.82% is on the low side compared to the rest of the industry. EAST is outperformed by 93.10% of its industry peers.
Industry RankSector Rank
ROA -47.82%
ROE N/A
ROIC N/A
ROA(3y)-44.62%
ROA(5y)-42.41%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EAST Yearly ROA, ROE, ROICEAST Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500 -500 1K

1.3 Margins

With a Gross Margin value of 8.90%, EAST is not doing good in the industry: 93.10% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of EAST has declined.
EAST does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 8.9%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-26.87%
GM growth 5Y-23.17%
EAST Yearly Profit, Operating, Gross MarginsEAST Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -50 -100 -150 -200

More info and screens

0

2. Health

2.1 Basic Checks

EAST does not have a ROIC to compare to the WACC, probably because it is not profitable.
EAST has more shares outstanding than it did 1 year ago.
The number of shares outstanding for EAST has been increased compared to 5 years ago.
The debt/assets ratio for EAST has been reduced compared to a year ago.
EAST Yearly Shares OutstandingEAST Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 500K 1M 1.5M
EAST Yearly Total Debt VS Total AssetsEAST Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

2.2 Solvency

Based on the Altman-Z score of -8.77, we must say that EAST is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of EAST (-8.77) is worse than 89.66% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -8.77
ROIC/WACCN/A
WACC6.07%
EAST Yearly LT Debt VS Equity VS FCFEAST Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M

2.3 Liquidity

A Current Ratio of 0.29 indicates that EAST may have some problems paying its short term obligations.
EAST's Current ratio of 0.29 is on the low side compared to the rest of the industry. EAST is outperformed by 89.66% of its industry peers.
EAST has a Quick Ratio of 0.29. This is a bad value and indicates that EAST is not financially healthy enough and could expect problems in meeting its short term obligations.
EAST has a worse Quick ratio (0.18) than 89.66% of its industry peers.
Industry RankSector Rank
Current Ratio 0.29
Quick Ratio 0.18
EAST Yearly Current Assets VS Current LiabilitesEAST Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

More info and screens

6

3. Growth

3.1 Past

EAST shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 79.90%, which is quite impressive.
The Revenue for EAST has decreased by -40.85% in the past year. This is quite bad
EAST shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.40% yearly.
EPS 1Y (TTM)79.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%48.75%
Revenue 1Y (TTM)-40.85%
Revenue growth 3Y-9.17%
Revenue growth 5Y11.4%
Sales Q2Q%-74.52%

3.2 Future

EAST is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.51% yearly.
The Revenue is expected to grow by 30.21% on average over the next years. This is a very strong growth
EPS Next Y56.38%
EPS Next 2Y34.94%
EPS Next 3Y26.51%
EPS Next 5YN/A
Revenue Next Year-0.77%
Revenue Next 2Y31.2%
Revenue Next 3Y30.21%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
EAST Yearly Revenue VS EstimatesEAST Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 5M 10M 15M 20M 25M
EAST Yearly EPS VS EstimatesEAST Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -5 -10 -15 -20 -25

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EAST. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EAST. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EAST Price Earnings VS Forward Price EarningsEAST Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EAST Per share dataEAST EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 -2 -3

4.3 Compensation for Growth

EAST's earnings are expected to grow with 26.51% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.94%
EPS Next 3Y26.51%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for EAST!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EASTSIDE DISTILLING INC

NASDAQ:EAST (1/24/2025, 8:00:01 PM)

After market: 0.8503 -0.04 (-4.11%)

0.8867

+0.01 (+0.88%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)11-14 2024-11-14/amc
Earnings (Next)N/A N/A
Inst Owners9.75%
Inst Owner Change-17.29%
Ins Owners5.01%
Ins Owner Change10.1%
Market Cap4.16M
Analysts82.86
Price Target3.57 (302.62%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)17.54%
Min EPS beat(2)-4.02%
Max EPS beat(2)39.1%
EPS beat(4)1
Avg EPS beat(4)-65.98%
Min EPS beat(4)-247.59%
Max EPS beat(4)39.1%
EPS beat(8)3
Avg EPS beat(8)-64.89%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-31.7%
Min Revenue beat(2)-75.73%
Max Revenue beat(2)12.33%
Revenue beat(4)1
Avg Revenue beat(4)-40.8%
Min Revenue beat(4)-75.73%
Max Revenue beat(4)12.33%
Revenue beat(8)1
Avg Revenue beat(8)-37.64%
Revenue beat(12)3
Avg Revenue beat(12)-23.56%
Revenue beat(16)3
Avg Revenue beat(16)-23.95%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.65
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-3.45
EYN/A
EPS(NY)-1.1
Fwd EYN/A
FCF(TTM)-0.37
FCFYN/A
OCF(TTM)-0.37
OCFYN/A
SpS1.36
BVpS-0.52
TBVpS-1.42
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -47.82%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 8.9%
FCFM N/A
ROA(3y)-44.62%
ROA(5y)-42.41%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-26.87%
GM growth 5Y-23.17%
F-Score3
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.29
Quick Ratio 0.18
Altman-Z -8.77
F-Score3
WACC6.07%
ROIC/WACCN/A
Cap/Depr(3y)66.85%
Cap/Depr(5y)70.3%
Cap/Sales(3y)7.35%
Cap/Sales(5y)8.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)79.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%48.75%
EPS Next Y56.38%
EPS Next 2Y34.94%
EPS Next 3Y26.51%
EPS Next 5YN/A
Revenue 1Y (TTM)-40.85%
Revenue growth 3Y-9.17%
Revenue growth 5Y11.4%
Sales Q2Q%-74.52%
Revenue Next Year-0.77%
Revenue Next 2Y31.2%
Revenue Next 3Y30.21%
Revenue Next 5YN/A
EBIT growth 1Y22.56%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year52.9%
EBIT Next 3Y46.83%
EBIT Next 5YN/A
FCF growth 1Y69.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y44.7%
OCF growth 3YN/A
OCF growth 5YN/A